WO2001075093A8 - Novel nucleic acids and polypeptides - Google Patents
Novel nucleic acids and polypeptidesInfo
- Publication number
- WO2001075093A8 WO2001075093A8 PCT/US2001/010484 US0110484W WO0175093A8 WO 2001075093 A8 WO2001075093 A8 WO 2001075093A8 US 0110484 W US0110484 W US 0110484W WO 0175093 A8 WO0175093 A8 WO 0175093A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- polypeptides
- novel nucleic
- novel
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01922987A EP1268762A4 (en) | 2000-03-31 | 2001-03-30 | Novel nucleic acids and polypeptides |
US10/240,145 US20030235883A1 (en) | 2000-03-31 | 2001-03-30 | Novel nucleic acids and polypeptides |
CA002404555A CA2404555A1 (en) | 2000-03-31 | 2001-03-30 | Novel nucleic acids and polypeptides |
AU2001249728A AU2001249728A1 (en) | 2000-03-31 | 2001-03-30 | Novel nucleic acids and polypeptides |
US10/291,128 US20050202422A1 (en) | 2000-03-31 | 2002-11-08 | Novel nucleic acids and polypeptides |
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54021700A | 2000-03-31 | 2000-03-31 | |
US09/540,217 | 2000-03-31 | ||
US64916700A | 2000-08-23 | 2000-08-23 | |
US09/649,167 | 2000-08-23 | ||
US09/668,680 | 2000-09-22 | ||
US09/668,680 US6436703B1 (en) | 2000-03-31 | 2000-09-22 | Nucleic acids and polypeptides |
US69561800A | 2000-10-23 | 2000-10-23 | |
US09/695,618 | 2000-10-23 | ||
US09/728,711 | 2000-11-30 | ||
US09/728,711 US20020061567A1 (en) | 2000-03-31 | 2000-11-30 | Novel nucleic acids and polypeptides |
US09/808,701 US6610536B2 (en) | 2000-03-31 | 2001-03-14 | Nucleic acids and polypeptides |
US09/808,701 | 2001-03-14 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/291,128 Continuation-In-Part US20050202422A1 (en) | 2000-03-31 | 2002-11-08 | Novel nucleic acids and polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001075093A1 WO2001075093A1 (en) | 2001-10-11 |
WO2001075093A8 true WO2001075093A8 (en) | 2002-07-25 |
Family
ID=27560113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/010484 WO2001075093A1 (en) | 2000-03-31 | 2001-03-30 | Novel nucleic acids and polypeptides |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1268762A4 (en) |
CA (1) | CA2404555A1 (en) |
WO (1) | WO2001075093A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1878795A3 (en) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
US7164001B2 (en) | 2000-01-20 | 2007-01-16 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
CA2409776A1 (en) * | 2000-06-16 | 2001-12-27 | Incyte Genomics, Inc. | G-protein coupled receptors |
WO2002050276A2 (en) * | 2000-12-18 | 2002-06-27 | Curagen Corporation | Proteins and nucleic acids encoding same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001057252A2 (en) * | 2000-02-04 | 2001-08-09 | Aeomica, Inc. | Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes |
WO2001060860A2 (en) * | 2000-02-17 | 2001-08-23 | Millennium Predictive Medicine, Inc. | Genes differentially expressed in human prostate cancer and their use |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
-
2001
- 2001-03-30 CA CA002404555A patent/CA2404555A1/en not_active Abandoned
- 2001-03-30 EP EP01922987A patent/EP1268762A4/en not_active Withdrawn
- 2001-03-30 WO PCT/US2001/010484 patent/WO2001075093A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001075093A1 (en) | 2001-10-11 |
EP1268762A1 (en) | 2003-01-02 |
EP1268762A4 (en) | 2003-08-27 |
CA2404555A1 (en) | 2001-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001075067A8 (en) | Novel nucleic acids and polypeptides | |
WO2001057188A3 (en) | Novel nucleic acids and polypeptides | |
WO2001057190A3 (en) | Novel nucleic acids and polypeptides | |
WO2002022660A3 (en) | Novel nucleic acids and polypeptides | |
WO2001066689A3 (en) | Novel nucleic acids and polypeptides | |
WO2002031111A3 (en) | Novel nucleic acids and polypeptides | |
WO2001088088A3 (en) | Novel nucleic acids and polypeptides | |
WO2002059260A3 (en) | Nucleic acids and polypeptides | |
WO2003054152A3 (en) | Novel nucleic acids and polypeptides | |
WO2003025148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002070539A3 (en) | Novel nucleic acids and polypeptides | |
WO2003023013A3 (en) | Novel nucleic acids and polypeptides | |
WO2002081731A3 (en) | Novel nucleic acids and polypeptides | |
WO2001053312A8 (en) | Novel nucleic acids and polypeptides | |
WO2001053455A3 (en) | Novel nucleic acids and polypeptides | |
WO2004009834A3 (en) | Novel nucleic acids and secreted polypeptides | |
WO2003029271A3 (en) | Novel nucleic acids and polypeptides | |
WO2004080148A3 (en) | Novel nucleic acids and polypeptides | |
WO2002018424A3 (en) | Nucleic acids and polypeptides | |
WO2004087874A3 (en) | Novel nucleic acids and polypeptides | |
WO2001079449A3 (en) | Novel nucleic acids and polypeptides | |
WO2001002571A3 (en) | An interleukin-1 receptor antagonist and uses thereof | |
WO2003080795A3 (en) | Novel nucleic acids and secreted polypeptides | |
WO2005049806A3 (en) | Novel nucleic acids and polypeptides | |
WO2001075068A3 (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2404555 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001922987 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10291128 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001922987 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10240145 Country of ref document: US |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001922987 Country of ref document: EP |